News & Events

• February 23, 2016
  

  Parkinson’s UK Announces Major Pharma Companies Sign Up to CPP

  Major pharma companies sign up to groundbreaking Parkinson’s consortium Seven of the world’s largest pharmaceutical companies have signed up to a groundbreaking consortium aimed at accelerating the development of safe and effective therapies for Parkinson’s. The Critical Path for Parkinson’s consortium will bring together leading academics; industry members AbbVie, AstraZeneca, Biogen, Eli Lilly and Company,......
• January 13, 2016
  

  Pediatric Trials Consortium 2015 Year-End Message

  Dear Colleagues, A few months ago we announced that the Critical Path Institute established the Pediatric Trials Consortium (PTC) with the goal of supporting the formation of a new, independent non-profit organization that will develop a network of clinical trial sites with the specific capability to conduct registration-quality clinical trials for new medical products for......
• November 9, 2015
  

  CPTR’s Relational Sequencing TB Data Platform (ReSeqTB) is highlighted on pages 59 and 60 of UNITAID’s “2015 Tuberculosis Diagnostics Technology and Market Landscape” report.

• November 1, 2015
  

  Building a Roadmap to Biomarker Qualification: Challenges and Opportunities

• August 31, 2015
  

  Collaboration is Making LIFE Better: Critical Path Institute Celebrates Key Milestones AZ Bionindustry Association